Former Netflix Exec: Personalization Crucial to Company's Success
*By Bridgette Webb*
Netflix has gone through a whirlwind of changes since its 1997 launch. Evolving from a DVD rental company to a global leader in video streaming that's disrupted an entire industry.
And a key reason for its growth, according to the company's vice president of product Gibson Biddle, has been the its ability to deliver personalized recommendations.
"Even in the early days, we were trying to get to know a member and their movie taste...and then magically connect them through algorithms," Biddle said in an interview on Cheddar Wednesday."
That strategy has helped Netflix grow its subscriber base to 125 million users worldwide. That reach is something that originally seemed outrageous to Biddle.
"In 2005 we put it out there that by 2010 we'd have 20 million subscribers," he said. "That felt audacious at the time."
Biddle left Netflix in 2010 and served as Chief Product Officer at Chegg until 2015.
Netflix reports earnings after the bell on Monday. It's expected to have added 6.2 million subscribers in the quarter, bringing its total to 131.2 million globally.
For the full segment, [click here.](https://cheddar.com/videos/netflixs-evolution)
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
